159 related articles for article (PubMed ID: 14607833)
1. Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain.
Shi N; Ye S; Bartlam M; Yang M; Wu J; Liu Y; Sun F; Han X; Peng X; Qiang B; Yuan J; Rao Z
J Biol Chem; 2004 Feb; 279(6):4962-9. PubMed ID: 14607833
[TBL] [Abstract][Full Text] [Related]
2. Role of Dok1 in cell signaling mediated by RET tyrosine kinase.
Murakami H; Yamamura Y; Shimono Y; Kawai K; Kurokawa K; Takahashi M
J Biol Chem; 2002 Sep; 277(36):32781-90. PubMed ID: 12087092
[TBL] [Abstract][Full Text] [Related]
3. NMR characterization of the near native and unfolded states of the PTB domain of Dok1: alternate conformations and residual clusters.
Gupta S; Bhattacharjya S
PLoS One; 2014; 9(2):e90557. PubMed ID: 24587391
[TBL] [Abstract][Full Text] [Related]
4. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of distinct interactions between Dok1 PTB domain and tyrosine-phosphorylated EGF receptor.
Zhang Y; Yan Z; Farooq A; Liu X; Lu C; Zhou MM; He C
J Mol Biol; 2004 Oct; 343(4):1147-55. PubMed ID: 15476828
[TBL] [Abstract][Full Text] [Related]
6. Interaction Analyses of 14-3-3ζ, Dok1, and Phosphorylated Integrin β Cytoplasmic Tails Reveal a Bi-molecular Switch in Integrin Regulation.
Chatterjee D; D'Souza A; Zhang Y; Bin W; Tan SM; Bhattacharjya S
J Mol Biol; 2018 Oct; 430(21):4419-4430. PubMed ID: 30243836
[TBL] [Abstract][Full Text] [Related]
7. An Alternative Phosphorylation Switch in Integrin β2 (CD18) Tail for Dok1 Binding.
Gupta S; Chit JC; Feng C; Bhunia A; Tan SM; Bhattacharjya S
Sci Rep; 2015 Jun; 5():11630. PubMed ID: 26108885
[TBL] [Abstract][Full Text] [Related]
8. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor.
Eck MJ; Dhe-Paganon S; Trüb T; Nolte RT; Shoelson SE
Cell; 1996 May; 85(5):695-705. PubMed ID: 8646778
[TBL] [Abstract][Full Text] [Related]
9. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain.
Ishiguro Y; Iwashita T; Murakami H; Asai N; Iida K; Goto H; Hayakawa T; Takahashi M
Endocrinology; 1999 Sep; 140(9):3992-8. PubMed ID: 10465268
[TBL] [Abstract][Full Text] [Related]
10. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
11. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
Melillo RM; Carlomagno F; De Vita G; Formisano P; Vecchio G; Fusco A; Billaud M; Santoro M
Oncogene; 2001 Jan; 20(2):209-18. PubMed ID: 11313948
[TBL] [Abstract][Full Text] [Related]
12. The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation.
Leppänen VM; Bespalov MM; Runeberg-Roos P; Puurand U; Merits A; Saarma M; Goldman A
EMBO J; 2004 Apr; 23(7):1452-62. PubMed ID: 15044950
[TBL] [Abstract][Full Text] [Related]
13. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
15. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
[TBL] [Abstract][Full Text] [Related]
16. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.
Chiariello M; Visconti R; Carlomagno F; Melillo RM; Bucci C; de Franciscis V; Fox GM; Jing S; Coso OA; Gutkind JS; Fusco A; Santoro M
Oncogene; 1998 May; 16(19):2435-45. PubMed ID: 9627110
[TBL] [Abstract][Full Text] [Related]
17. Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.
Anthis NJ; Haling JR; Oxley CL; Memo M; Wegener KL; Lim CJ; Ginsberg MH; Campbell ID
J Biol Chem; 2009 Dec; 284(52):36700-36710. PubMed ID: 19843520
[TBL] [Abstract][Full Text] [Related]
18. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.
Grimm J; Sachs M; Britsch S; Di Cesare S; Schwarz-Romond T; Alitalo K; Birchmeier W
J Cell Biol; 2001 Jul; 154(2):345-54. PubMed ID: 11470823
[TBL] [Abstract][Full Text] [Related]
19. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.
Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH
J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342
[TBL] [Abstract][Full Text] [Related]
20. An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding.
Oxley CL; Anthis NJ; Lowe ED; Vakonakis I; Campbell ID; Wegener KL
J Biol Chem; 2008 Feb; 283(9):5420-6. PubMed ID: 18156175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
